Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD4CD56 hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype
Mirjana Urosevic, Curdin Conrad, Jivko Kamarashev, et al.
Human Pathology (2005) Vol. 36, Iss. 9, pp. 1020-1024
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Novel markers of normal and neoplastic human plasmacytoid dendritic cells
Teresa Marafioti, Jennifer C. Paterson, Erica Ballabio, et al.
Blood (2008) Vol. 111, Iss. 7, pp. 3778-3792
Open Access | Times Cited: 223
Plasmacytoid Dendritic Cells
Armin G. Jegalian, Fabio Facchetti, Elaine S. Jaffe
Advances in Anatomic Pathology (2009) Vol. 16, Iss. 6, pp. 392-404
Open Access | Times Cited: 181
CD4+/CD56+ Hematodermic Tumor
Marco Herling, Dan Jones
American Journal of Clinical Pathology (2007) Vol. 127, Iss. 5, pp. 687-700
Open Access | Times Cited: 176
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia
Francine Garnache‐Ottou, Jean Feuillard, Christophe Ferrand, et al.
British Journal of Haematology (2009) Vol. 145, Iss. 5, pp. 624-636
Open Access | Times Cited: 174
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?
Stéphane Dalle, M. Beylot‐Barry, Martine Bagot, et al.
British Journal of Dermatology (2009) Vol. 162, Iss. 1, pp. 74-79
Closed Access | Times Cited: 155
Neoplasms derived from plasmacytoid dendritic cells
Fabio Facchetti, Marta Cigognetti, Simona Fisogni, et al.
Modern Pathology (2016) Vol. 29, Iss. 2, pp. 98-111
Open Access | Times Cited: 121
Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities
Remco Dijkman, Remco van Doorn, Károly Szuhai, et al.
Blood (2006) Vol. 109, Iss. 4, pp. 1720-1727
Open Access | Times Cited: 157
Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
David Vremec, Meredith O’Keeffe, Hubertus Hochrein, et al.
Blood (2006) Vol. 109, Iss. 3, pp. 1165-1173
Open Access | Times Cited: 154
Blastic plasmacytoid dendritic cell neoplasm
Fabio Facchetti, Marco Ungari, D. Marocolo, et al.
Hematology Meeting Reports (formerly Haematologica Reports) (2009) Vol. 3, Iss. 3, pp. 145-147
Closed Access | Times Cited: 125
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer
Chalid Assaf, Sylke Gellrich, Sean Whittaker, et al.
Journal of Clinical Pathology (2006) Vol. 60, Iss. 9, pp. 981-989
Open Access | Times Cited: 121
Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus
Jennifer M. McNiff, Daniel H. Kaplan
Journal of Cutaneous Pathology (2007) Vol. 35, Iss. 5, pp. 452-456
Closed Access | Times Cited: 114
A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children’s Oncology Group
Lisa Eidenschink Brodersen, Todd A. Alonzo, Andrew J. Menssen, et al.
Leukemia (2016) Vol. 30, Iss. 10, pp. 2077-2080
Open Access | Times Cited: 68
Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
Francine Garnache‐Ottou, Jean Feuillard, Philippe Saas
British Journal of Haematology (2007) Vol. 136, Iss. 4, pp. 539-548
Open Access | Times Cited: 101
Signalling pathways leading to IFN‐α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications
Cristiana Guiducci, Robert L. Coffman, Franck J. Barrat
Journal of Internal Medicine (2008) Vol. 265, Iss. 1, pp. 43-57
Closed Access | Times Cited: 91
Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms
David L. Jaye, Cissy Geigerman, Marco Herling, et al.
Modern Pathology (2006) Vol. 19, Iss. 12, pp. 1555-1562
Open Access | Times Cited: 88
An Updated Approach to the Diagnosis of Myeloid Leukemia Cutis
Danielle M. P. Cronin, Tracy I. George, Uma Sundram
American Journal of Clinical Pathology (2009) Vol. 132, Iss. 1, pp. 101-110
Open Access | Times Cited: 86
CD4+/CD56+ Hematodermic Neoplasm (“Blastic Natural Killer Cell Lymphoma”)
Monika Pilichowska, Mark D. Fleming, Jack L. Pinkus, et al.
American Journal of Clinical Pathology (2007) Vol. 128, Iss. 3, pp. 445-453
Open Access | Times Cited: 79
Primary cutaneous lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Reinhard Dummer, M. Dreyling
Annals of Oncology (2008) Vol. 19, pp. ii72-ii76
Open Access | Times Cited: 64
Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm
Nikhil Sangle, Robert L. Schmidt, Jay Patel, et al.
Modern Pathology (2014) Vol. 27, Iss. 8, pp. 1137-1143
Open Access | Times Cited: 48
Dendritic cells and innate defense against tumor cells
Evelyn Ullrich, Cédric Menard, Caroline Flament, et al.
Cytokine & Growth Factor Reviews (2008) Vol. 19, Iss. 1, pp. 79-92
Closed Access | Times Cited: 55
Immunophenotypic Analysis of Myeloperoxidase-Negative Leukemia Cutis and Blastic Plasmacytoid Dendritic Cell Neoplasm
Danielle M. P. Cronin, Tracy I. George, Kaaren K. Reichard, et al.
American Journal of Clinical Pathology (2012) Vol. 137, Iss. 3, pp. 367-376
Open Access | Times Cited: 44
A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-α by stimulation via Toll-like receptors and present antigens to naïve T cells
Miwako Narita, Norihiro Watanabe, Akie Yamahira, et al.
Leukemia Research (2009) Vol. 33, Iss. 9, pp. 1224-1232
Closed Access | Times Cited: 43
Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm
Keiko Hashikawa, Daisuke Niino, Shinichiro Yasumoto, et al.
Journal of the American Academy of Dermatology (2011) Vol. 66, Iss. 2, pp. 278-291
Closed Access | Times Cited: 38
Blastic Plasmacytoid Dendritic Cell Neoplasm without Cutaneous Lesion at Presentation: Case Report and Literature Review
Huijie Wang, Junning Cao, Xiaonan Hong
Acta Haematologica (2012) Vol. 127, Iss. 2, pp. 124-127
Closed Access | Times Cited: 35
Type I IFN innate immune response to adenovirus-mediated IFN-γ gene transfer contributes to the regression of cutaneous lymphomas
Mirjana Urosevic, Kazuyasu Fujii, Boris Calmels, et al.
Journal of Clinical Investigation (2007) Vol. 117, Iss. 10, pp. 2834-2846
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top